Remove 2023 Remove Homecare Remove Hospice Remove Personal care
article thumbnail

Addus HomeCare to Accelerate Acquisition Activity

Hospice News

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Its hospice segment earned $53.1 million, up 12.6%

Homecare 253
article thumbnail

The Most Significant Hospice Deals So Far in 2023

Hospice News

Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among the most common types of transactions. But in 2023, private equity activity slowed from its formerly frenzied pace.

2023 274
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. In Q1 2023, Addus’ hospice segment brought in $49.08

article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. NYSE: HUM) for $2.8

2024 274
article thumbnail

Addus Projects ‘Strong, Steady’ Hospice Growth Amid Lingering Pandemic Census Headwinds

Hospice News

Addus HomeCare Corp. NASDAQ: ADUS) saw hospice growth in 2023, despite lingering pandemic-related challenges around daily census. The company anticipates growth in its personal care business in 2024, which will have a reverberating impact in its hospice and home health service lines.

2024 147
article thumbnail

Palliative Care Momentum Growing Among Hospice Providers

Hospice News

Hospices are increasingly eying palliative care as a promising growth opportunity, prioritizing expansion in that field over other health care service lines. Survey respondents included nearly 330 hospice and palliative care industry professionals, including owners, executive leaders and managers, among others.